Monoclonal antibody specific for IDH1 R132H mutation
- PMID: 19798509
- DOI: 10.1007/s00401-009-0595-z
Monoclonal antibody specific for IDH1 R132H mutation
Abstract
IDH1 R132H mutations occur in approximately 70% of astrocytomas and oligodendroglial tumors. We developed a mouse monoclonal antibody targeting the IDH1 R132H mutation. Here, we show the high specificity and sensitivity of this antibody on Western blots and tissue sections from formalin fixed paraffin embedded tumor specimens. This antibody is highly useful for tumor classification, in detecting single infiltrating tumor cells and for the characterization of the cellular role of mutant IDH1 protein.
Comment in
-
GFAP, Ki67 and IDH1: perhaps the golden triad of glioma immunohistochemistry.Acta Neuropathol. 2009 Nov;118(5):603-4. doi: 10.1007/s00401-009-0600-6. Acta Neuropathol. 2009. PMID: 19847448 No abstract available.
Similar articles
-
Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing.Brain Tumor Pathol. 2011 Apr;28(2):115-23. doi: 10.1007/s10014-011-0023-7. Epub 2011 Feb 23. Brain Tumor Pathol. 2011. PMID: 21344322
-
Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology.Acta Neuropathol. 2011 Feb;121(2):241-52. doi: 10.1007/s00401-010-0770-2. Epub 2010 Nov 11. Acta Neuropathol. 2011. PMID: 21069360
-
Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma.Ann Diagn Pathol. 2012 Aug;16(4):255-9. doi: 10.1016/j.anndiagpath.2011.11.003. Epub 2012 Mar 23. Ann Diagn Pathol. 2012. PMID: 22445362
-
Value and limitations of immunohistochemistry and gene sequencing for detection of the IDH1-R132H mutation in diffuse glioma biopsy specimens.J Neuropathol Exp Neurol. 2011 Aug;70(8):715-23. doi: 10.1097/NEN.0b013e31822713f0. J Neuropathol Exp Neurol. 2011. PMID: 21760534
-
A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation.Biochem Biophys Res Commun. 2009 Dec 18;390(3):547-51. doi: 10.1016/j.bbrc.2009.10.001. Epub 2009 Oct 7. Biochem Biophys Res Commun. 2009. PMID: 19818334 Free PMC article.
Cited by
-
Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival.J Neurooncol. 2015 Sep;124(2):237-45. doi: 10.1007/s11060-015-1829-7. Epub 2015 Jun 2. J Neurooncol. 2015. PMID: 26033547
-
Absolute Metabolite Quantification in Individuals with Glioma and Healthy Individuals Using Whole-Brain Three-dimensional MR Spectroscopic and Echo-planar Time-resolved Imaging.Radiology. 2024 Sep;312(3):e232401. doi: 10.1148/radiol.232401. Radiology. 2024. PMID: 39315894
-
Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological response.Cancer Immunol Immunother. 2015 Jun;64(6):707-16. doi: 10.1007/s00262-015-1674-8. Epub 2015 Mar 14. Cancer Immunol Immunother. 2015. PMID: 25772149 Free PMC article. Clinical Trial.
-
[Personalized neurooncology].Nervenarzt. 2013 Aug;84(8):937-42. doi: 10.1007/s00115-013-3758-z. Nervenarzt. 2013. PMID: 23775285 Review. German.
-
Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma.AJNR Am J Neuroradiol. 2012 Aug;33(7):1349-55. doi: 10.3174/ajnr.A2950. Epub 2012 Feb 9. AJNR Am J Neuroradiol. 2012. PMID: 22322613 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous